FOXO Technologies Company Profile
FOXO Technologies Inc is a healthcare services and technology company operating four divisions—rural hospitals, mental and behavioral health, data and biospecimen sourcing, and epigenetics diagnostics—primarily generating revenue through its Healthcare segment, with a market cap of $426K as of June 2026, reporting $18.37M revenue and significant net losses in FY 2025, headquartered in West Palm Beach, FL, and competing with firms like Pacific BioSciences and Lucid Diagnostics while having acquired five companies including Vector Biosource.
Overview
FOXO Technologies Inc is a healthcare services and technology company. It operates four synergistic divisions:
- 1.Rural hospital division
- 2.Mental and behavioral health division
- 3.Information, data, and biospecimen sourcing division
- 4.Epigenetics diagnostics and interpretation division
The company manages its business in three reportable segments:
- Healthcare (includes Myrtle, RCHI, and SCCH)
- Life Science Services (includes Vector)
- Labs
The majority of revenue is generated from the Healthcare segment.
Former Names
- Life Epigenetics
- YouSurance
- FOXO BioScience
- FOXO
- Delwinds Insurance Acquisition
- InsurTech Holdings
Corporate Office
- 477 South Rosemary Avenue, Suite 224, West Palm Beach, FL 33401, United States
Primary Industry
- Hospitals/Inpatient Services
Other Industries
- Practice Management (Healthcare)
- Biotechnology
Stock Exchange
- PINX
Verticals
- Big Data
- Artificial Intelligence & Machine Learning
- InsurTech
- FinTech
- Life Sciences
Stock Performance (as of 12-Jun-2026)
- Market Cap: $426K
- Shares: 4.26B
- Average Volume: 12.2M
- EPS: $0.05
Financials Summary (as of 31-Mar-2026)
| Metric | TTM 31-Mar-2026 | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| EV | $10,484K | $10,352K | $41,130K | $5,691K |
| Revenue | $18,366K | $16,368K | $4,052K | $145K |
| EBITDA | ($9,322K) | ($8,599K) | ($7,276K) | ($24,108K) |
| Net Income | ($13,266K) | ($12,430K) | ($12,406K) | ($26,451K) |
| Total Assets | $45,786K | $44,578K | $41,708K | $726K |
| Total Debt | $12,173K | $10,966K | $14,255K | $4,993K |
Competitors
- Pacific BioSciences of California (Menlo Park, CA)
- Bestow (Dallas, TX)
- Ladder (Palo Alto, CA)
- Lucid Diagnostics (New York, NY)
Acquisitions (5)
- Vector Biosource (Laboratory Services, acquired 22-Sep-2025)
- Big South Fork Medical Center (Hospitals/Inpatient Services, acquired 17-Sep-2024)
- Myrtle Recovery Centers (Hospitals/Inpatient Services, acquired 14-Jun-2024)
- Delwinds Insurance Acquisition (SPAC, acquired 15-Sep-2022)
- FOXO Life (Life and Health Insurance, acquired 20-Aug-2021)
Exits (1)
- FOXO Life (Exited 20-Aug-2021)
Affiliates (Subsidiaries)
- Myrtle Recovery Centers (Oneida, TN, founded 2023)
- Vector Biosource (Stoughton, MA, founded 2023)
- Delwinds Insurance Acquisition (Houston, TX, founded 2020)
- Big South Fork Medical Center (Oneida, TN, founded 1955)
FAQs
Where is FOXO Technologies headquartered?
West Palm Beach, FL.
What is the size of FOXO Technologies?
192 total employees.
What industry is FOXO Technologies in?
Hospitals/Inpatient Services.
Is FOXO Technologies a private or public company?
Public company.
What is FOXO Technologies’s stock symbol?
FOXO.
What is the current market cap of FOXO Technologies?
$426K.
What is FOXO Technologies’s current revenue?
Trailing twelve month revenue: $18.4M.
Who are FOXO Technologies’s competitors?
Pacific BioSciences of California, Bestow, Ladder, Lucid Diagnostics.
What is FOXO Technologies’s annual earnings per share (EPS)?
$0.05 (12 months).